Pharmacokinetics of Tacrolimus in Kidney Transplant Recipients: Twice Daily Versus Once Daily Dosing

American Journal of Transplantation

Volumn 4, Issue 4, 2004, Pages 621-625

  Hardinger, Karen L ^a   Park, Jeong M ^b   Schnitzler, Mark A ^a   Koch, Matthew J ^a   Miller, Brent W ^a   Brennan, Daniel C ^a  

^a BARNES JEWISH HOSPITAL   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Dosing interval; Pharmacokinetics; Tacrolimus

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; MACROLIDE; TACROLIMUS;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; COST BENEFIT ANALYSIS; DRUG DOSE REGIMEN; DRUG SAFETY; FEMALE; HUMAN; KIDNEY GRAFT; MALE; PATIENT COMPLIANCE; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SIDE EFFECT;

ADULT; AREA UNDER CURVE; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PILOT PROJECTS; TACROLIMUS; TIME FACTORS; TREATMENT OUTCOME;

EID: 1942534049     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2004.00383.x     Document Type: Article

References (17)

1. Nankivell BJ, Hibbins M, Chapman JR. Diagnostic utility of whole blood cyclosporine measurements in renal transplantation using triple therapy. Transplantation 1994; 58: 989-996.
2. Min DI, Perry PJ, Chen H-Y, Hunsicker LG. Cyclosporine trough concentrations in predicting allograft rejection and renal toxicity up to 12 months after renal transplantation. Pharmacotherapy 1998; 18: 282-287.
3. Mahalati K, Belitsky P, Sketris I, West K, Panek R. Neoral monitoring by simplified sparse sampling area under the concentration-time curve. Transplantation 1999; 68: 55-62.
4. Grant D, Kneteman N, Tchervenkov J et al. Peak cyclosporine levels (Cmax) correlate with freedom from liver graft rejection. Transplantation 1999; 67: 1133-1137.
5. Jusko WJ, Piekoszewski W, Klintmalm GB et al. Pharmacokinetics of tacrolimus in liver transplant patients. Clin Pharmacol Ther 1995; 57: 281-290.
6. Jain AB, Todo S, Fung JJ et al. Correlation of rejection episodes with FK506 dosage, FK506 level, and steroids following primary orthotopic liver transplant. Transplant Proc 1991; 23: 3023-3025.
7. Backman L, Nicar M, Levy M et al. FK506 trough levels in whole blood and plasma in liver transplant recipients: correlation with clinical events and side effects. Transplantation 1994; 57: 519-525.
8. Schwarts M, Holst B, Facklam D et al. FK 506 in liver transplantation: correlation of whole blood levels with efficacy and toxicity. Transplant Proc 1995; 27: 1107.
9. Undre N, van Hooff J, Christiaans M et al. Low systemic exposure to tacrolimus correlates with acute rejection. Transplant Proc 1999; 31: 296-298.
10. Cantarovich M, Barkun JS, Tchervenkov JI, Besner J-G, Aspeslet L, Metrakos P. Comparison of Neoral dose monitoring with cyclosporine trough levels versus 2-hr postdose levels in stable liver transplant patients. Transplantation 1998; 66: 1621-1627.
11. Cantarovich M, Besner J-G, Barkun JS, Elstein E, Loertscher R. Two-hour cyclosporine level determination is the appropriate tool to monitor Neoral therapy 1. Clin Transplant 1998; 12: 243-249.
12. Levy GA, Lake JR, Beauregard-Zollinger L, Prestele H. Improved clinical outcomes for liver transplant recipients using cyclosporine blood level monitoring based in two-hour post-dose levels. Transplantation 2000; 69 (Suppl.): S387.
13. Lemmer B. Chronopharmacokinetics: implications for drug treatment. J Pharm Pharmacol 1999; 51: 887-890.
14. Min DI, Chen H-Y, Lee M-K et al. Time-dependent disposition of tacrolimus and its effect on endothelin-1 in liver allograft recipients. Pharmacotherapy 1997; 17: 457-463.
15. Bekersky I, Dressler D, Mekki Q. Effect of low- and high-fat meals on tacrolimus absorption following 5 mg single oral doses to healthy human subjects. J Clin Pharmacol 2001; 41: 176-182.
16. Bekersky I, Dressler D, Mekki Q. Effect of time of meal consumption on bioavailability of a single oral 5 mg tacrolimus dose. J Clin Pharmacol 2001; 41: 289-297.
17. Christiaans M, van Duijnhoven E, Beysens T, Undre N, Schafer A, van Hooff J. Transplant Proc 1998; 30: 1271-1273.